Site Search
Displaying results 421 - 430 of 573
Resource | Presentations,
Presentation on Balancing Health and Trade: Doha Declaration on TRIPS and Public Health at Regional Consultation and Planning Workshop “Use of TRIPS Flexibilities to Access Affordable ARVs in Asia” Bangkok 29-31 May 2012
Resource | Presentations,
Presentation on International Trade Rules and Access to Treatment (an Overview) at Regional Consultation and Planning Workshop “Use of TRIPS Flexibilities to Access Affordable ARVs in Asia” Bangkok 29-31 May 2012
Resource | Presentations,
Presentation on The TRIPS Plus Enforcement Landscape at Regional Consultation and Planning Workshop “Use of TRIPS Flexibilities to Access Affordable ARVs in Asia” Bangkok 29-31 May 2012
Resource | Presentations,
Presentation on ASEAN: Access To Affordable Medicines by Health and Communicable Diseases Division, ASEAN Secretariat at Regional Consultation and Planning Workshop "Use of TRIPS Flexibilities to Access Affordable ARVs in Asia" Bangkok 29-31 May 2012
Resource | Presentations,
Presentation on Increasing South-South co-operation through the India-Africa partnership and the Global South at Regional Consultation and Planning Workshop “Use of TRIPS Flexibilities to Access Affordable ARVs in Asia” Bangkok 29-31 May 2012
Resource | Presentations,
Presentation on The Shifting Winds: What Future for Sustainable Treatment? at Regional Consultation and Planning Workshop “Use of TRIPS Flexibilities to Access Affordable ARVs in Asia” Bangkok 29-31 May 2012.
Resource | Presentations,
Summary of country mapping exercise: Regional Consultation and Planning Workshop Use of TRIPS Flexibilities to Access Affordable ARVs in Asia. Bangkok, Thailand 29-31 May (2012)
Resource | Publications,
Recent developments suggest that substantial clinical and programmatic advantages can come from adopting a single, universal regimen both to treat HIV-infected pregnant women and to prevent mother-to-child transmission of HIV. This streamlining should maximize PMTCT programme performance through better alignment and linkages with antiretroviral therapy (ART) programmes at every level of service delivery. One of WHO’s two currently recommended PMTCT antiretroviral (ARV) programme options, Option B, takes this unified approach.
Now a new, third option (Option B+) proposes further evolution—not only providing the same triple ARV drugs to all HIV-infected pregnant women beginning in the antenatal clinic setting but also continuing this therapy for all of these women for life.
This programmatic update is meant to provide a current perspective for countries on the important changes and new considerations arising since publication of WHO’s PMTCT ARV guidelines, 2010 version, especially as a number of countries are now preparing to adopt Option B+. WHO has begun a comprehensive revision of all ARV guidelines, including guidance on ARVs for pregnant women, planned for release in early 2013.
Resource | Publications,
This study on positive women's access to reproductive and maternal health care and services was conducted in six South and South East Asian countries: Bangladesh, Cambodia, India, Indonesia, Nepal and Viet Nam. Countries were selected to include a mix of low and concentrated epidemics and coverage of services that support women to have HIV free babies (usually referred to as prevention of mother to child transmission or PMTCT). The objective of the study is to examine the experience of access to reproductive and maternal health care and services by HIV positive women who have been pregnant in the past 18 months.
Resource | Publications,
In June 2011, Viet Nam participated in the UN General Assembly High-Level Meeting on AIDS in New York. At this meeting, Viet Nam renewed its commitment to the HIV response and adopted new targets by signing the 2011 Political Declaration on HIV/AIDS: Intensifying our Efforts to Eliminate HIV/AIDS. This report also reflects a national consensus on key achievements and challenges in the HIV response in Viet Nam in the years 2010 and 2011.
Viet Nam has also finalized its new National Strategy on HIV/AIDS Prevention and Control to 2020, with a vision to 2030, developed with broad consultation. The targets of the new National Strategy echo those of the 2011 Political Declaration, and illustrate Viet Nam’s commitment to the vision of zero new infections, zero discrimination and zero AIDS-related deaths.